ZL11n is a novel nitric oxide-releasing derivative of farnesylthiosalicylic acid that induces apoptosis in human hepatoma HepG2 cells via MAPK/mitochondrial pathways (Q39534519)
Jump to navigation
Jump to search
scientific article published on 20 May 2011
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | ZL11n is a novel nitric oxide-releasing derivative of farnesylthiosalicylic acid that induces apoptosis in human hepatoma HepG2 cells via MAPK/mitochondrial pathways |
scientific article published on 20 May 2011 |
Statements
1 reference
ZL11n is a novel nitric oxide-releasing derivative of farnesylthiosalicylic acid that induces apoptosis in human hepatoma HepG2 cells via MAPK/mitochondrial pathways (English)
1 reference
Lifang Yang
1 reference
Yong Ling
1 reference
Zhenzhen Zhang
1 reference
Qian Zhao
1 reference
Jianxin Tang
1 reference
Hui Ji
1 reference
Yihua Zhang
1 reference
20 May 2011
1 reference
1 reference
409
1 reference
4
1 reference
752-757
1 reference
Identifiers
1 reference
1 reference